Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
Plotinus's Profile
Displaying 151-200 of 630 result(s).
CYDY CytoDyn Inc
05/16/2024 2:51:37 PM
“The prospective clinical trials, (15)
CYDY CytoDyn Inc
05/03/2024 11:35:38 AM
My memory on the timing of “treep (4)
CYDY CytoDyn Inc
05/02/2024 8:15:09 PM
Granted I do not have laser insight (28)
CYDY CytoDyn Inc
05/02/2024 6:20:15 PM
Not sure if that OHM indications li (1)
CYDY CytoDyn Inc
04/28/2024 3:37:13 PM
FWIW, for the safari browser I have
CYDY CytoDyn Inc
04/28/2024 3:26:56 PM
I am simply using an iPhone 13 with
CYDY CytoDyn Inc
04/28/2024 1:36:28 PM
I use Safari on iPhone and am not e (1)
CYDY CytoDyn Inc
04/18/2024 5:23:56 PM
“There has to also be money side (20)
CYDY CytoDyn Inc
04/18/2024 7:26:00 AM
“I think I hope that we don’t u (7)
CYDY CytoDyn Inc
04/11/2024 5:20:31 PM
Wow, Dr Jay not waiting till Monday (4)
CYDY CytoDyn Inc
04/11/2024 5:18:16 PM
“Apparently, they believed the fi (17)
CYDY CytoDyn Inc
04/11/2024 3:54:26 PM
“Do you get the sense that Jeff M (7)
CYDY CytoDyn Inc
04/11/2024 2:40:12 PM
Bitchy little tyrant is an understa (22)
CYDY CytoDyn Inc
04/09/2024 10:18:02 AM
“how can the medical/pharma commu (15)
CYDY CytoDyn Inc
04/08/2024 3:21:26 PM
Going for deux cartes, pair of aces (3)
CYDY CytoDyn Inc
03/30/2024 12:14:40 PM
Good point this is not official and (2)
CYDY CytoDyn Inc
03/30/2024 12:08:28 PM
Excellent thought! How best to get (4)
CYDY CytoDyn Inc
03/28/2024 6:11:25 PM
According to Pixar, if it’s Ratat (3)
CYDY CytoDyn Inc
03/28/2024 1:28:30 PM
Here is an abstract related to thei (18)
CYDY CytoDyn Inc
03/27/2024 9:36:08 AM
Footnote on sotatercept: some drugs (14)
CYDY CytoDyn Inc
03/27/2024 8:47:45 AM
The link below has a succinct summa (16)
CYDY CytoDyn Inc
03/16/2024 4:33:56 PM
Gilead knew, and from there commenc (14)
CYDY CytoDyn Inc
03/15/2024 12:29:33 PM
The answer to that is best served u (8)
CYDY CytoDyn Inc
03/15/2024 10:53:57 AM
Madrigal north of 5 billion market (10)
CYDY CytoDyn Inc
03/14/2024 2:43:55 PM
One last footnote on unraveling the (12)
CYDY CytoDyn Inc
03/14/2024 2:11:25 PM
Per CGC’s recent post the Long Co (12)
CYDY CytoDyn Inc
03/14/2024 8:17:14 AM
Perhaps Kanecia should wake up and (3)
CYDY CytoDyn Inc
03/13/2024 7:32:16 PM
Anonymous note to NIH, stop fumblin (17)
CYDY CytoDyn Inc
03/13/2024 5:15:55 PM
Per your link 700,000 Americans hav (19)
CYDY CytoDyn Inc
03/06/2024 10:50:23 AM
I have zero anxiety about the resul (12)
CYDY CytoDyn Inc
03/06/2024 10:37:58 AM
“Surely would have peaked quickly (3)
CYDY CytoDyn Inc
03/06/2024 10:26:40 AM
A couple of quick comments: 1) A st (17)
CYDY CytoDyn Inc
03/06/2024 9:34:17 AM
I don’t know for sure but suspect (8)
CYDY CytoDyn Inc
03/05/2024 4:22:34 PM
Importantly, CRP is not some arcane (6)
CYDY CytoDyn Inc
03/05/2024 4:17:38 PM
The big reveal from the call for me (8)
CYDY CytoDyn Inc
03/05/2024 1:01:11 PM
Inclusion criteria is elevated CRP (2)
CYDY CytoDyn Inc
02/29/2024 8:43:50 PM
To put some perspective on the cont (7)
CYDY CytoDyn Inc
02/29/2024 2:42:34 PM
Flipping is generally a losing stra (2)
CYDY CytoDyn Inc
02/29/2024 11:56:59 AM
It will take time for the communica (7)
CYDY CytoDyn Inc
02/20/2024 9:35:22 AM
“Chronic inflammation has been im (9)
CYDY CytoDyn Inc
02/18/2024 7:11:13 PM
I agree with Jake2212, Amarex is a (15)
CYDY CytoDyn Inc
02/16/2024 12:28:29 PM
Gilead is not the only one pushing (9)
CYDY CytoDyn Inc
02/16/2024 11:10:24 AM
Gordian knot cut, in Alexander the (1)
CYDY CytoDyn Inc
02/14/2024 5:01:41 PM
Related to this post on pancreatic
CYDY CytoDyn Inc
02/14/2024 7:50:30 AM
Circling back to pancreatic cancer, (7)
CYDY CytoDyn Inc
02/06/2024 4:02:17 PM
Under the quick to results category (16)
CYDY CytoDyn Inc
02/02/2024 5:49:27 PM
Spent many a year up in Wisconsin†(4)
CYDY CytoDyn Inc
02/02/2024 3:43:33 PM
I think you answered the question. (17)
CYDY CytoDyn Inc
02/02/2024 2:17:34 PM
Correction…Temozolimide is not a
CYDY CytoDyn Inc
02/02/2024 2:12:57 PM
From the PR: “In December 2023, t (19)
Go to page:
  • << First
  • < Previous
  • 3
  • 4
  • Next >

Recent Articles

  • Therapy Ideas for Your Innovative Health and Wellness Center
  • Meta's Bold Move: Why Investing $250M in AI Talent Matters
  • Accessory Dwelling Unit Plans in 2025: Smart Designs for Purpose, Space & Long-Term Value
  • Impact of Tariff Loophole Elimination on Global Commerce
  • Berkshire Hathaway's $3.8 Billion Write-Down on Kraft Heinz
  • Unveiling Success: President Trump's Achievements This Week
  • Berkshire Hathaway's Caution as Cash Reserves Hit $344 Billion
  • Elon Musk Addresses Control Concerns Amid Shareholder Influence
  • Unlocking Fitness Franchise Opportunities: Your Guide to a Stronger Business Future
  • President Trump’s Vision: Turning America’s Aspirations into Reality
  • Home Sellers Adjust to Buyer Hesitation Amid Price Challenges
  • Two Smart Paths to Franchise Ownership: Medical and Mosquito Control Businesses
  • Investor Alert: Class Actions for Neogen, Alto, RxSight, and Replimune
  • TrimIQ UK Launch: A Revolutionary Approach to Wellness
  • Exploring Arialief: A Natural Solution for Nerve Pain Relief
  • Unlocking the Secrets of No Deposit Free Spins at Wild Casino
  • Sam Altman's Urgent Caution on AI Risks and Innovations
  • Matsato Knife Revolutionizes Culinary Tools in Key Markets
  • Discover the Benefits of Audizen Drops for Nerve Health
  • Niche Matters: How Focusing Drives RIA Growth and Client Loyalty
  • Significant Movement in Bitcoin as Long-Dormant Wallet Empties
  • Reddit Investors: Join the Class Action Against Fraud Today
  • Investor Alert: Securities Fraud Class Action Lawsuit Against Hims & Hers
  • Perplexity's Success: Aravind Srinivas Challenges Tech Titans
  • Insights from Bill Ackman: Investing During Market Uncertainty
  • Berkshire Hathaway Faces Challenges Amidst Market Uncertainty
  • Unveiling Underrated Stocks to Watch for Future Growth
  • Revolutionizing Connectivity: The Future of Starlink Technology
  • Understanding Your Rights as a Simulations Plus, Inc. Investor
  • Shiba Inu Coin Flourishes as HashJ Introduces New Contracts
  • Recent Stock Insights: Key Players in the Market Breakdown
  • Risetcar's Autonomous Taxis Set to Transform Jakarta's Transport
  • Pan-Mass Challenge: Cyclists Unite for Groundbreaking Research
  • Bitcoin Swift Presale Enters New Phase with Innovative AI Rewards
  • Celebrating Financial Health: Global Impact Champions Awards Launch
  • Avast Emerges as the Top Choice for Antivirus Software
  • FAA Implements Changes to Helicopter Routes after Tragedy
  • Navigating High-Beta Stocks: Echoes of the Dot-Com Boom
  • Understanding the Real Dynamics Behind Portfolio Performance
  • Overview of Financière de Tubize’s Half-Year Performance
  • Financière de Tubize Unveils Promising Financial Results for 2025
  • Legal Actions from Shareholders: Insights on Sarepta and Petco
  • Kuvi.ai Unveils Agentic Finance OS in Seed Funding Expansion
  • SHARC Energy Advancing Financing with New Convertible Debentures
  • Important Class Action Update for Hims & Hers Health Investors
  • Class Action Lawsuit Emerges Against Flywire Corporation
  • Important Update for Sable Offshore Investors: Act Now
  • Class Action Notice for Neogen Investors: Key Details Inside
  • Tempus AI Faces Legal Challenges Following SEC Allegations
  • Replimune Group Faces Class Action: Key Insights for Investors
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site